Back to search

Article

Oral Ursodeoxycholic Acid Therapy Failed to Mitigate SARS-CoV-2 Omicron Variants BA.5.2 Infection

2023-03-27

Abstract excerpt

<h4>Background: </h4> Ursodeoxycholic acid (UDCA) was reported to reduce susceptibility to SARS-CoV-2 infection by downregulating farnesoid X receptor (FXR) -ACE2 signaling. However, we found a different story in real-world clinical studies. Objectives We attempted to verify whether UDCA can effectively prevent SARS-CoV-2 transmission or have positive therapeutic effects in a real-world clinical study. Methods W...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f72c7747-e4d3-5e9b-be81-49d0bea232fb
DOI
10.21203/rs.3.rs-2717720/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oral Ursodeoxycholic Acid Therapy Failed to Mitigate SARS-CoV-2 Omicron Variants BA.5.2 InfectionDOI 10.21203/rs.3.rs-2717720/v1
Select a neighboring publication to make it the new centre.